Subscribe To Our Newsletter
Subscribe To Our Newsletter
Healthcare professionals and businesses that received an unrequested fax from Indegene on or around February 7, 2020, offering a $250 honorarium for an anti-Parkinson’s medical record review, can file a claim to recover up to $250 in cash under the federal Telephone Consumer Protection Act (TCPA).
If you or your medical practice received an unexpected junk fax offering money for a medical review in early 2020, you may be eligible to receive a cash payment of up to $250. Indegene Inc. and several of its business affiliates have agreed to establish a $4.71 million class action settlement fund to resolve claims that the company distributed illegal, unsolicited fax advertisements across the United States.
The lawsuit alleges that the healthcare marketing company violated federal law by blasting out thousands of commercial faxes without obtaining prior written consent from recipients or offering standard opt-out instructions. While Indegene denies any wrongdoing, the company reached a financial agreement to settle the matter and avoid the costs and delays of prolonged litigation.
At ClassActionU.org, our goal is to empower everyday people and healthcare providers to hold large corporations accountable when they ignore consumer protection laws. Below is everything you need to know about the Indegene TCPA settlement, who qualifies for cash benefits, and how you can submit your claim before the upcoming court deadline.
The legal action against Indegene stems from a federal privacy law known as the Telephone Consumer Protection Act. Congress enacted the TCPA to protect individuals and businesses from unwanted telemarketing communications, including automated phone calls, unsolicited text messages, and junk faxes. Under the TCPA, companies are strictly prohibited from transmitting unsolicited advertisements to a fax machine unless they have explicit prior permission or an established business relationship with the recipient.
According to court filings in the lawsuit, titled Progressive Health and Rehab Corp. v. Indegene Inc. et al., the company sent thousands of unrequested commercial faxes to healthcare practices and professionals around February 7, 2020. The plaintiffs alleged that these faxes served as marketing material aimed at recruiting professionals for clinical studies without meeting federal statutory standards.
Unsolicited faxes do more than just irritate busy office personnel. They tie up dedicated communication lines, consume expensive paper and ink cartridges, and interrupt daily work activities. When corporations bypass consent requirements to push commercial offers, federal laws give consumers and business owners the right to hold them responsible.
The faxes at the center of this legal action specifically focused on a research program involving anti-Parkinson’s disease medications. The document transmitted by Indegene was titled “Medical Record Review of the Impact of Adverse Events Associated with the Use of Current anti-Parkinson’s Disease Medications on Patient Clinical Therapeutics and Outcomes Trajectories in the U.S.”
In the transmission, Indegene offered a $250 honorarium per eligible patient record reviewed. Plaintiffs in the lawsuit argued that despite framing the communication as a professional opportunity, the fax operated as an illegal advertisement under federal guidelines because it was sent without verified consent.
Court records indicate that approximately 18,869 individual fax advertisements were successfully transmitted during this specific campaign. Because each transmission represents a potential statutory violation under the TCPA, the cumulative liability prompted the defendants—including Indegene Inc., Indegene Encima Inc., Indegene Wincere Incorporated, and Indegene Healthcare LLC—to negotiate a global settlement structure.
You may be eligible for a settlement payment if you or your business received the specific fax offer from Indegene. Eligibility hinges on several specific criteria established by the settlement agreement:
Timing: The qualifying fax must have been successfully received on or around February 7, 2020.
Content: The fax was titled regarding the medical record review for anti-Parkinson’s disease medications.
Incentive: The message mentioned an honorarium offer of $250 per eligible patient.
Ownership: You or your business owned or operated the receiving fax number at the time the transmission occurred in February 2020.
If you received official notice of this settlement in the mail or via email, your notice likely contains a unique Claim Number and PIN assigned specifically to your business or individual records. However, even if you did not retain the original notice, you can still verify your eligibility by providing the fax number that received the transmission.
Eligible class members who file a valid, timely claim form can receive a cash payment of up to $250. The ultimate payout amount per claimant depends heavily on the total number of approved claims submitted by the conclusion of the filing period.
The $4,717,250 total settlement fund created by Indegene will be distributed to cover multiple court-approved costs before paying out claimants:
| Allocation Category | Estimated Amount or Purpose |
| Total Settlement Fund | $4,717,250.00 |
| Attorneys’ Fees & Expenses | Up to $1,651,037.50 |
| Class Representative Award | Up to $15,000.00 |
| Settlement Administration Costs | Court-approved noticing and processing expenses |
| Net Cash Payouts | Remaining funds distributed pro rata to valid claimants (up to $250 each) |
Because payments are calculated on a pro rata basis, the individual recovery amount could be adjusted depending on final participation rates. If fewer people file claims, approved claimants are more likely to receive the maximum $250 cap. Cash payments will be distributed as paper checks mailed directly to the address provided on the claim form.
The Telephone Consumer Protection Act remains one of the strongest federal laws designed to protect privacy rights and prevent corporate intrusion. Passed by Congress in 1991 and periodically updated, the law establishes strict boundaries for commercial solicitors.
Under the TCPA, businesses that send unsolicited commercial faxes face statutory damages ranging from $500 up to $1,500 per individual violation if the conduct is found to be willful. These clear penalties exist to deter companies from treating private communication equipment as their own marketing channels.
Class action lawsuits serve as a vital mechanism under the TCPA. When individual damages like a single unwanted fax might not justify hiring a private lawyer, combining thousands of similar claims into a unified action forces corporations to take privacy mandates seriously and compensate affected parties fairly.
Filing a claim in the Indegene TCPA settlement is straightforward and requires no out-of-pocket payment or legal representation. You can complete the entire procedure online or submit a physical claim form by mail or fax.
To file your claim online:
Visit the official settlement portal at indegenetcpasettlement.com.
Enter the Claim Number and PIN listed on the settlement notice you received. If you do not have these codes, follow the instructions on the site to submit using your verified fax number.
Confirm your current mailing address where you wish your settlement check to be delivered.
Verify that you owned or leased the receiving fax number in February 2020.
Submit your completed claim before the official deadline.
If you prefer to submit a paper claim form, you can download and print the PDF from the official settlement site. Completed paper forms can be sent via fax to 952-997-0136 or mailed directly to the settlement administrator at:
Progressive v Indegene, Inc.
c/o Analytics Consulting LLC
PO Box 2007
Chanhassen, MN 55317-2007
Key Deadline: Your claim form must be submitted online or postmarked no later than December 9, 2026.
If you meet the class criteria, you have three primary legal options available regarding the settlement:
File a Claim: Submit your form by December 9, 2026, to receive your cash payment. By doing so, you give up your right to sue Indegene independently regarding these specific fax claims.
Exclude Yourself (Opt-Out): If you wish to bring your own separate lawsuit against Indegene for these faxes, you must formally exclude yourself in writing by December 9, 2026. You will receive no money from this settlement if you opt out.
Do Nothing: If you do nothing, you will receive no cash payout, and you will give up your right to sue the company over these specific legal claims in the future.
The court presiding over the case, the U.S. District Court, has scheduled a Final Approval Hearing for January 12, 2027. During this hearing, the judge will determine whether the settlement is fair, reasonable, and adequate, and decide on final approval of attorneys’ fees and administrative expenses. Cash payments will be distributed after the court grants final approval and any potential appeals are resolved.
When corporations violate federal privacy statutes, millions of dollars in potential settlement funds often go unclaimed simply because people do not take a few minutes to complete a form. At ClassActionU.org, we believe everyday consumers and healthcare professionals deserve transparency, fairness, and accountability.
New cases and investigations, settlement deadlines, and news straight to your inbox.
